ClinicalTrials.Veeva

Menu

Pseudoexfoliation and Chronic Kidney Disease

C

Corum State Hospital

Status

Completed

Conditions

Chronic Kidney Disease

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Background: Pseudoexfoliation (PEX) is characterised by the deposition of fibrillar material in an eye structures and many other parts of the body including kidneys and blood vessels. As both PEX and chronic kidney disease (CKD) are associated with oxidative stress and endothelial dysfunction we studied if the risk of PEX was increased in patients with CKD.

Methods: Patients over age 40 with the diagnosis of CKD were included in the study. Chronic kidney disease was diagnosed as decreased glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m². Study groups were arranged as group 1 consisting of HD receiving patients, group 2 consisting of stage 1-4 CKD patients and group 3 consisting of patients with normal kidney functions (control group). Demographic properties and the rate of PEX were evaluated and compaired between the groups.

Enrollment

358 patients

Sex

All

Ages

40 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients with chronic kidney disease stage 1-5

Exclusion criteria

  • History of eye trauma or surgery

Trial design

358 participants in 3 patient groups

Dialysis patients
Description:
Patients with stage 5 chronic kidney disease undergoing haemodialysis
Chronic kidney disease patients
Description:
Stage 1-4 Chronic kidney disease patients
Control group
Description:
Patients with normal renal functions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems